Allogeneic marrow transplantation for multiple myeloma: An analysis of risk factors on outcome

Blood

Volumn 88, Issue 7, 1996, Pages 2787-2793

  Bensinger, William I ^a,b   Buckner, C Dean ^a   Anasetti, Claudio ^a   Clift, Reginald ^a   Storb, Rainer ^a   Barnett, Todd ^a   Chauncey, Tom ^a   Shulman, Howard ^a   Appelbaum, Frederick R ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TREATMENT FAILURE;

EID: 0029822773     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.7.2787.bloodjournal8872787     Document Type: Article

References (34)

1. Kubagawa H, Vogler LB, Capra JD, Conrad ME, Lawton AR, Cooper MD: Studies on the clonal origin of multiple myeloma: Use of individually specific (idiotype) antibodies to trace the oncogenic event to its earliest point of expression in B-cell differentiation. J Exp Med 150:792, 1979
2. Epstein J, Xiao H, He X-Y: Markers of multiple hematopoietic-cell lineages in multiple myeloma. N Engl J Med 322:664, 1990
3. Gregory WM, Richards MA, Malpas JS: Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trails. J Clin Oncol 10:334, 1992
4. Boccadoro M, Marmont F, Tribalto M, Avvisati G, Andriani A, Barbui T, Cantonetti M, Carotenuto M, Comotti B, Dammacco F, Frieri R, Gallamini A, Gallone G, Giovangrossi P, Grignani F, Lauta VM, Liberati M, Musto P, Neretto G, Petrucci MT, Resegotti L, Pileri A, Mandelli F: Multiple myeloma: VMCP/BAP alternating combination chemotherapy is not superior to melphalan and prednisone even in high-risk patients. J Clin Oncol 9:444, 1991
5. Kyle RA: Long-term survival in multiple myeloma. N Engl J Med 308:314, 1983
6. Osserman EF, Dire LB, Dire J, Sherman WH, Hersman JA, Storb R: Identical twin marrow transplantation in multiple myeloma. Acta Haematol 68:215, 1982
7. McElwain TJ, Powles RL: High-dose intravenous melphalan for plasma cell leukaemia and myeloma. Lancet 1:822, 1983
8. Fefer A, Cheever MA, Greenberg PD: Identical twin (syngeneic) marrow transplantation for hematologic cancers. J Natl Cancer Inst 76:1269, 1986
9. Gahrton G, Tura S, Flesch M, Gratwohl A, Gravett P, Lindeberg A, Lucarelli G, Michallet M, Reiffers J, Ringden O, Nikoskelainen J, Van Lint MT, Venant JP, Zwaan FE: Allogeneic bone marrow transplantation in 24 patients with multiple myeloma reported to the EBMT Registry. Hematol Oncol 6:181, 1988
10. Gahrton G, Ringden O, Lönnqvist B, Lindquist R, Ljungman P: Bone marrow transplantation in three patients with multiple myeloma. Acta Med Scand 219:523, 1986
11. Gahrton G, Ringden O, Lönnqvist B: Bone marrow transplantation in multiple myeloma. Acta Med Scand 219:433, 1986
12. Gahrton G, Tura S, Ljungman P, Belanger B, Brandt L, Cavo M, Facon T, Granena A, Gratwohl A, Löwenberg B, Nikoskelainen J, Reiffers J, Samson D, Selby P, Volin L, for the European Group for Bone Marrow Transplantation: Allogeneic bone marrow transplantation in multiple myeloma. N Engl J Med 325:1267, 1991
13. Tura S, Cavo M, Baccarani M, Ricci P, Gobbi M: Bone marrow transplantation in multiple myeloma. Scand J Haematol 36:176, 1986
14. Buckner CD, Fefer A, Bensinger WI, Storb R, Durie BG, Appelbaum FR, Petersen CB, Weiden P, Clift RA, Sanders JE, Sullivan KM, Witherspoon RP, Hill R, Martin P, Thomas ED: Marrow transplantation for malignant plasma cell disorders: Summary of the Seattle experience. Eur J Haematol 43:186, 1989
15. Bensinger WI, Buckner CD, Clift RA, Petersen FB, Bianco JA, Singer JW, Appelbaum FR, Dalton W, Beatty P, Fefer A, Storb R, Thomas ED, Hansen JA: Phase I study of busulfan and cyclophosphamide in preparation for allogeneic marrow transplant for patients with multiple myeloma. J Clin Oncol 10:1492, 1992
16. Reece DE, Shepherd JD, Klingemann HG, Sutherland HJ, Nantel SH, Barnett MJ, Spinelli JJ: Treatment of myeloma using intensive therapy and allogeneic bone marrow transplantation. Bone Marrow Transplant 15:117, 1995
17. Anderson KC, Andersen J, Soiffer R, Freedman AS, Rabinowe SN, Robertson MJ, Spector N, Blake K, Murray C, Freeman A, Coral F, Marcus KC, Mauch P, Nadler LM, Ritz J: Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma. Blood 82:2568, 1993
18. Gahrton G, Tura S, Ljungman P, Blade J, Brandt L, Cavo M, Facon T, Gratwohl A, Hagenbeek A, Jacobs P, De Laurenzi A, Van Lint M, Michallet M, Nikoskelainen J, Reiffers J, Samson D, Verdonck L, De Witte T, Volin L: Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma. J Clin Oncol 13:1312, 1995
19. Durie BGM, Salmon SE: A clinical staging system for multiple myeloma: Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 36:842, 1975
20. Anasetti C, Amos D, Beatty PG, Appelbaum FR, Bensinger W, Buckner CD, Clift R, Doney K, Martin PJ, Mickelson E, Nisperos B, O'Quigley J, Ramberg R, Sanders JE, Stewart P, Storb R, Sullivan KM, Witherspoon RP, Thomas ED, Hansen JA: Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 320:197, 1989
21. Anasetti C, Howe C, Petersdorf EW, Martin PJ, Hansen JA: Marrow transplants from HLA-matched unrelated donors: An NMDP update and the Seattle experience. Bone Marrow Transplant 13:693, 1994
22. Oken MM: Multiple myeloma. Med Clin North Am 68:757, 1984
23. Bianco JA, Appelbaum FR, Nemunaitis J, Almgren J, Andrews F, Kettner P, Shields A, Singer JW: Phase I-II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation. Blood 78:1205, 1991
24. Thomas ED, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD: Bone-marrow transplantation. N Engl J Med 292:832, 1975
25. Storb R, Deeg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Doney K, Farewell V, Hansen J, Hill R, Lum L, Martin P, McGuffin R, Sanders J, Stewart P, Sullivan K, Witherspoon R, Yee G, Thomas ED: Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 314:729, 1986
26. Nash RA, Storb R: FK506-based immunosuppression for the prevention of acute GVHD after marrow transplantation, in Lieberman R (ed): Principles of Drug Design in Transplantation and Autoimmunity. New York, NY, Raven (in press)
27. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, Lerner KG, Thomas ED: Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18:295, 1974
28. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
29. Gratwohl A, Hermans J, Niederwieser D, Frassoni F, Arcese W, Gahrton G, Bandini G, Carreras E, Vernant JP, Bosi A: Bone marrow transplantation for chronic myeloid leukemia: Long-term results. Chronic leukemia working party of the European group for bone marrow transplantation. Bone Marrow Transplant 12:509, 1993
30. 2 microglobulin in myeloma: A Southwest Oncology Group Study. Blood 75:823, 1990
31. Bataille R, Durie BGM, Grenier J, Sany J: Prognostic factors and staging in multiple myeloma: A reappraisal. J Clin Oncol 4:80, 1986
32. Durie BGM, Salmon SE, Moon TE: Pretreatment tumor mass, cell kinetics, and prognosis in multiple myeloma. Blood 55:364, 1980
33. Clift RA: Marrow transplantation for chronic myeloid leukemia, in Buckner CD, Clift RA (eds): Technical and Biological Components of Marrow Transplantation, Norwell, MA, Kluwer Academic, 1995
34. Varterasian M, Ratanatharathorn V, Karanes C, Uberti J, Momin R, Abella E, Lum LG, Heilbrun LK, Sensenbrenner LL: Bone marrow transplantation for multiple myeloma: The Wayne State experience. Bone Marrow Transplant 15:328, 1995